DGX Insider Filing: Karthik Kuppusamy Surrenders 123 Shares for Tax Withholding
Rhea-AI Filing Summary
The filing reports insider activity by Karthik Kuppusamy, SVP, Clinical Solutions at Quest Diagnostics (DGX). On 08/13/2025 he had a disposition of 123 shares of Quest Diagnostics common stock executed under code F at a price of $175.91 per share; the filer states this sale was made solely to cover tax withholding on vested restricted stock units. Following the reported transaction, Kuppusamy beneficially owned 8,338 shares directly, plus 358 shares indirectly via a trust and 1,628 shares held in the 401(k) plan, with the 401(k) amount provided by the plan administrator based on current account balances.
Positive
- Insider retains meaningful direct ownership of 8,338 shares, indicating continued alignment with shareholder interests
- Additional indirect holdings include 358 shares via trust and 1,628 shares in the 401(k) plan, showing ongoing participation in company equity programs
Negative
- Disposition of 123 shares was recorded, though the filing states this was solely to satisfy tax withholding obligations
Insights
TL;DR: Small, non-discretionary sale to satisfy tax withholding; insider retains meaningful direct and indirect holdings.
The transaction code F and the filing explanation indicate this was a routine disposition to cover tax obligations arising from RSU vesting rather than a voluntary opportunistic sale. The amount disposed (123 shares) at $175.91 is modest relative to the reported direct holding of 8,338 shares. Holdings also include shares in a trust (358) and a 401(k) allocation (1,628), which suggests ongoing equity ownership alignment with company performance. This filing is informational and not materially transformative for investors.
TL;DR: Filing documents routine tax-withholding sale and confirms continued insider exposure to company stock.
The explanatory notes explicitly state the disposition was solely to cover tax withholding from RSU vesting, which supports customary corporate governance practices for equity compensation. The use of an attorney-in-fact signature is noted and appears administrative. No indication of accelerated selling, option exercises, or derivative transactions is present. From a governance perspective, the report documents compliance with Section 16 reporting requirements and preserves transparency about insider ownership levels.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 123 | $175.91 | $22K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
